Soliqua

Soliqua Description

insulin glargine + lixisenatide

Manufacturer:

sanofi-aventis

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Soliqua Solostar 100 units/ml + 50 microgram/ml solution for injection in a pre-filled pen: Each pre-filled pen contains 300 units of insulin glargine* and 150 micrograms lixisenatide in 3 ml solution.
Each ml contains 100 units of insulin glargine and 50 micrograms lixisenatide.
Each dose step contains 1 unit of insulin glargine and 0.5 micrograms of lixisenatide.
Soliqua Solostar 100 units/ml + 33 microgram/ml solution for injection in a pre-filled pen: Each pre-filled pen contains 300 units of insulin glargine and 100 micrograms Lixisenatide in 3 ml solution.
Each ml contains 100 units of insulin glargine and 33 micrograms lixisenatide.
Each dose step contains 1 unit of insulin glargine and 0.33 micrograms of lixisenatide.
*Insulin glargine is produced by recombinant DNA technology in Escherichia coli.
The dose window on the pen shows the number of dose steps.
Excipient(s) with known effects: Each ml contains 2.7 milligrams of metacresol as preservative.
Excipients/Inactive Ingredients: Glycerol 85%, Methionine, Metacresol, Zinc chloride, Concentrated hydrochloric acid (for pH adjustment), Sodium hydroxide (for pH adjustment), Water for injections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in